Tortoise Capital Advisors L.L.C. cut its stake in Danaher Co. (NYSE:DHR) by 3.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,453 shares of the conglomerate’s stock after selling 308 shares during the period. Tortoise Capital Advisors L.L.C.’s holdings in Danaher were worth $1,451,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Solstein Capital LLC bought a new stake in Danaher during the 4th quarter worth approximately $422,000. BerganKDV Wealth Management LLC grew its position in Danaher by 474.5% during the 4th quarter. BerganKDV Wealth Management LLC now owns 2,752 shares of the conglomerate’s stock worth $422,000 after acquiring an additional 2,273 shares during the last quarter. PFG Advisors grew its position in Danaher by 0.3% during the 4th quarter. PFG Advisors now owns 27,560 shares of the conglomerate’s stock worth $4,307,000 after acquiring an additional 72 shares during the last quarter. Cleararc Capital Inc. grew its position in Danaher by 1.8% during the 3rd quarter. Cleararc Capital Inc. now owns 8,719 shares of the conglomerate’s stock worth $1,259,000 after acquiring an additional 152 shares during the last quarter. Finally, Johanson Financial Advisors Inc. bought a new stake in Danaher during the 4th quarter worth approximately $200,000. 79.72% of the stock is owned by institutional investors and hedge funds.
In other news, SVP Angela S. Lalor sold 18,267 shares of the firm’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $161.49, for a total value of $2,949,937.83. Following the transaction, the senior vice president now directly owns 56,782 shares in the company, valued at approximately $9,169,725.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP William King sold 26,370 shares of the firm’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $160.23, for a total value of $4,225,265.10. Following the completion of the transaction, the senior vice president now owns 22,427 shares in the company, valued at $3,593,478.21. The disclosure for this sale can be found here. Insiders sold a total of 297,385 shares of company stock worth $48,153,397 over the last 90 days. 11.40% of the stock is owned by corporate insiders.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, January 30th. The conglomerate reported $1.28 EPS for the quarter, beating the Zacks’ consensus estimate of $1.25 by $0.03. The firm had revenue of $4.87 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a return on equity of 11.50% and a net margin of 15.09%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company earned $1.28 EPS. As a group, analysts expect that Danaher Co. will post 5.38 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a $0.18 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.17. This represents a $0.72 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend is Thursday, March 26th. Danaher’s dividend payout ratio (DPR) is currently 15.38%.
DHR has been the topic of a number of research analyst reports. Cowen restated a “buy” rating and set a $170.00 price target on shares of Danaher in a research report on Monday, February 3rd. Credit Suisse Group increased their price target on Danaher from $151.00 to $160.00 and gave the stock an “outperform” rating in a research report on Thursday, December 19th. Zacks Investment Research lowered Danaher from a “hold” rating to a “sell” rating and set a $168.00 price target on the stock. in a research report on Tuesday, January 14th. Citigroup decreased their price target on Danaher from $195.00 to $160.00 and set a “buy” rating on the stock in a research report on Friday, March 20th. Finally, Bank of America increased their price target on Danaher from $165.00 to $188.00 and gave the stock a “buy” rating in a research report on Friday, January 31st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $166.41.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: Outstanding Shares
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.